Literature DB >> 1512512

Trp64----nonsense mutation in the lipoprotein lipase gene.

D L Sprecher1, J Kobayashi, M Rymaszewski, I J Goldberg, B V Harris, P S Bellet, D Ameis, R L Yunker, D M Black, E A Stein.   

Abstract

A lipoprotein lipase (LpL) gene defect has been identified, a G----A transition at nucleotide position 446 of exon 3, resulting in a premature termination codon (Trp----stop) at amino acid residue 64. This defect was identified in a Type I hyperlipoproteinemic subject with an amino acid residue 194 defect in the other allele. Plasma lipoprotein values as well as LpL mass and activity in postheparin plasma were determined in the subjects with the residue 64 defect and in other LpL-deficient heterozygotes. LpL mass levels in both the Type I and the other subject with a 64 LpL defect were markedly reduced. This may be explained by rapid degradation of LpL protein or decreased secretion from the 64 defective allele. Alternatively, the marked reduction or absence of mass associated with the 64 defect may be due to synthesis of a severely truncated protein which escapes immunologic detection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512512

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Assessment of French patients with LPL deficiency for French Canadian mutations.

Authors:  L Foubert; J L De Gennes; J P Lagarde; E Ehrenborg; A Raisonnier; J P Girardet; M R Hayden; P Benlian
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

2.  Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.

Authors:  Esther M M Ooi; Betsy S Russell; Eric Olson; Sam Z Sun; Margaret R Diffenderfer; Alice H Lichtenstein; Leonard Keilson; P Hugh R Barrett; Ernst J Schaefer; Dennis L Sprecher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

3.  Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.

Authors:  D E Wilson; A Hata; L K Kwong; A Lingam; J Shuhua; D N Ridinger; C Yeager; K C Kaltenborn; P H Iverius; J M Lalouel
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction.

Authors:  Jee Lee; Ira J Goldberg
Journal:  J Clin Lipidol       Date:  2008-02       Impact factor: 4.766

5.  Identification of a novel LPL nonsense variant and further insights into the complex etiology and expression of hypertriglyceridemia-induced acute pancreatitis.

Authors:  Xiao-Yao Li; Na Pu; Wei-Wei Chen; Xiao-Lei Shi; Guo-Fu Zhang; Lu Ke; Bo Ye; Zhi-Hui Tong; Yu-Hui Wang; George Liu; Jian-Min Chen; Qi Yang; Wei-Qin Li; Jie-Shou Li
Journal:  Lipids Health Dis       Date:  2020-04-07       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.